My new idea for FDA’s life cycle regulation for the non-SaMD: Allowing voluntary submission of validation data of open-source LLMs to help doctors to choose LLMs for clinical research and applications. ELHS Institute starts to release validated fine-tuned Llama3.1-8B models for predicting high-impact diseases, making it easy for doctors to evaluate these LLMs in clinical settings.
The democratization of GenAI in healthcare has just begun, driven by the nature of GenAI and guided by the principle of human-machine collaboration. ore...
The first in a series of free practical training webinars designed to teach doctors, medical students, and healthcare professionals how to quickly start using their own LLM copilots for healthcare. [In Chinese]